Profile: Guava Technologies, Inc. develops, designs and manufactures devices for biotechnology and medical markets. We offer products for research, clinical and bio process applications. Our products include HIV or AIDS monitoring, viacount cell counting and viability assay, antibody quantification assay, apoptosis assay suite, cell cycle assay, cytotoxicity assay, cell proliferation assay and benchtop cell analysis systems. We also provide flow cytometry systems for cell biology research, drug discovery and developments. Our auto CD4/CD4% HIV monitoring device is a two-color direct immunofluorescence reagent kit for enumeration of mature CD4+ T lymphocytes, and the determination of CD4 T cells as a percent of total lymphocytes in human blood. The kit consists of an antibody cocktail, a proprietary mixture of anti-human lymphocyte antibodies conjugated to the tandem dye phycoerythrin (PE)-Cy5, and a monoclonal anti-human CD4 antibody conjugated to PE and Guava® 1X lyzing solution to lyse erythrocytes. The viacount assay provides rapid and reliable determinations of viability & total cell count on all systems.

The company was founded in 1998.

FDA Registration Number: 3004422899